Menu Close

Articles on Pfizer-BioNTech vaccine

Displaying 21 - 40 of 148 articles

The FDA and CDC are recommending use of a third shot, or “booster dose” for certain groups of people in the U.S. Patrick T. Fallon/AFP via Getty Images

Tense decision-making as CDC joins FDA in recommending Pfizer booster shot for 65 & up, people at high risk and those with occupational exposure to COVID-19

Fault lines between the FDA and CDC regulatory processes have been on full display in the decisions over which groups of Americans should receive the Pfizer booster shot.
In the reluctance to vaccinate, there is a lack of trust and understanding of the scientific process. Better communication would help rebuild bridges. The Canadian Press/Paul Chiasson

A researcher’s view on COVID-19 vaccine hesitancy: The scientific process needs to be better explained

Before the pandemic, the public perceived science as infallible and inaccessible. But the opening up of research to the general public has changed that perception.
Protesters gather at Indiana University in June 2021 to demonstrate against mandatory COVID-19 vaccinations for students, staff and faculty. SOPA Images/LightRocket via Getty Images

Forceful vaccine messages backfire with holdouts – how can it be done better?

Subtly shifting the crafting and delivery of public health messaging on COVID-19 vaccines could go a long way toward persuading many of the unvaccinated to get the shot.
September 11, 2021 marks the 18 month anniversary of the WHO declaring the COVID-19 outbreak a pandemic. summerphotos/Stock via Getty Images Plus

18 months of the COVID-19 pandemic – a retrospective in 7 charts

A lot has happened since the WHO declared the coronavirus outbreak a pandemic. A portrait in data highlights trends in everything from case counts, to research publications, to variant spread.
People getting vaccinated may still have questions about COVID-19 vaccines, like why it takes two doses — and then two weeks — to take full effect. THE CANADIAN PRESS/Ryan Remiorz

I work at a COVID-19 vaccine clinic. Here’s what people ask me when they’re getting their shot — and what I tell them

A medical student answers questions he gets asked at a COVID-19 vaccine clinic: Efficacy versus real-world effectiveness, immune response and how the mRNA vaccines compare to vaccines already in wide use.
FDA approval of Pfizer’s COVID-19 vaccine may boost vaccination rates among those who have been hesitant to get the shot. (AP Photo/Jessica Hill)

Pfizer’s COVID-19 vaccine now has full FDA approval. Here’s what that means for unvaccinated people, organizations and pharma

The U.S. FDA has approved the first COVID-19 vaccine. How is approval different from emergency use authorization, and what difference will it make to a vaccine that’s already in global use?

Top contributors

More